The market for active pharmaceutical ingredients for animal health will integrate inquisition with innovation


The global animal health active pharmaceutical ingredients market is expected to grow at a good rate over the next few years. Virtual consultations are one of the current trends. They reduce the spread of contagious diseases, thus facilitating better efficiency. The gap in the supply-demand ratio could also be bridged in this way. With this practice followed, developing economies would benefit better, as the cost of travel could be reduced.

The Animal Health Active Pharmaceutical Ingredients Market is intended to achieve 4,600 million US dollars To 7.3% CAGR Between 2025. The healthcare vertical is moving in the direction of gadgets. The current scenario is such that it is not necessary to make an appointment for weeks / months to be treated. Real-time diagnosis and course of treatment might be possible. This simultaneous surveillance and treatment is sure to take the healthcare industry by storm over the next 10 years.

The Global Animal Health Active Pharmaceutical Ingredients (APIs) Market is expected to register impressive expansion at 7.3% CAGR during the forecast period 2017 to 2025, according to a recent study by Persistence Market Research (PMR). PMR Study Believes Market Will Grow With Revenue valued at US $ 5,216.1 million in 2017 to reach US $ 9,162.2 million by 2025-end.

Planning for the future? Get access to a sample report on the Active Pharmaceutical Ingredients for Animal Health Market!

Company Profiles

  • Glenmark Pharmaceuticals Ltd.
  • Zoetis Inc.
  • Eli Lilly & Co.
  • Sanofi Winthrop Industrie (CEPiA)
  • Indukern, SA
  • Ofichem BV
  • P&R SpA (Olon SpA)
  • Lonza Group SA
  • Huvepharma
  • ouro fino saude animal
  • Blanver Farmoquimica E Farmaceutica SA
  • Zhejiang Hisun Pharmaceutical Co. Ltd
  • Changzhou Yabang-Qh Pharmachem Co., Ltd.
  • Shanghai Pharmtech Co. Ltd.
  • Ningxia Tairui Pharma CO. Ltd.
  • Shaanxi Hanjiang Pharmaceutical Group Co., Ltd.
  • Sequent Scientific Ltd.
  • NGL Fine Chem Ltd.
  • Omkar Specialty Chemicals Limited
  • Excel Industries Ltd.
  • Others

Limited insurance or government intervention ensures a smooth flow to market growth in Asia-Pacific

Asia Pacific (APAC) will continue to be the most lucrative region in the global animal health active pharmaceutical ingredients market, with sales posting the second highest CAGR through 2025. APAC has remained l ‘one of the largest API providers, at affordable costs.

APAC governments have invested and focused on local API manufacturing facilities. The favorable policies proposed by these governments have diverted the attention of API manufacturers by moving their production bases to APAC countries, such as India and China.

In addition, limited insurance or government intervention allows for smooth market growth in these regions.

However, animal health API products made in APAC countries do not meet regulatory standards, and there is growing concern about the quality of APIs, especially those produced in China and India. Western regulators are becoming increasingly strict in inspecting APIs produced in these regions.

Manufacturers also face challenges in bridging the gap between cost and quality of APIs. These factors will restrain the growth of the APAC market.

How about revitalizing the strategy driven funnel to stay ahead in the animal health active pharmaceutical ingredients market?

Europe will remain the second largest market for animal health APIs

Europe will remain the second market for active pharmaceutical ingredients for animal health. The main healthcare companies are located in Europe, which in turn has boosted the need for veterinary APIs in the region. The consumption of veterinary drugs in Europe has increased considerably in recent years. Spain is considered the largest consumer of veterinary antimicrobial APIs in the EU.

In addition, the increasing improvements in animal productivity have spurred the growth of the animal health industry in this region. These impacts are expected to increase the growth of the API for animal health market in Europe.

However, the pharmaceutical industry in Europe has expressed concern about the potential short-term impacts of REACH regulations. This will likely lead to a decrease in the supply of materials or reagents, which are not pre-registered by EU suppliers.

Thinking of introducing a quirky product / technology to the animal health active pharmaceutical ingredient market? Go to “Buy Now” for our Animal Health Active Pharmaceutical Ingredient Market Report!

In addition, dynamic changes in Europe’s macroeconomic environment, such as Brexit, have had an impact on intra-European trade and the pharmaceutical sector as a whole. These factors could restrain the growth of the API for animal health market in Europe.

Pest control will remain the largest adopted APIs on the market

Antiparasitics will continue to be the largest adopted API on the market, followed by anti-infective. Antiparasitic sales are expected to register the fastest expansion, representing the largest revenues by 2025. In contrast, sales of anesthetics and NSAIDs will remain comparatively lower than those of antiparasitics and anti-parasitic drugs. -infectious.

Access related reports-

Global market research on Veterinary anti-infectives: The antiparasitic agent segment is expected to be the least attractive segment by drug class

Global market research on Composition of medicines for animals: CNS Agents To Lead Market Expansion Over Next Years

Global market research on Animal health: Industry growth will be driven by veterinary hospitals

Global market research on Animal pest control: Pharmacy and Drugstore Distribution Channels Segment Expected to Record Strong Revenue Growth Through 2026

About Us:

Persistence Market Research is here to provide businesses with a one stop solution to improve customer experience. It is committed to gathering the appropriate feedback after going through personalized interactions with customers to add value to the customer experience by acting as the “missing” link between “customer relationships” and “business results”. “. The best possible returns are guaranteed there.

Contact us:

Persistence market research

Address – 305 Broadway, 7th Floor, New York City,

NY 10007 United States

US Phone – + 1-646-568-7751

United States-Canada Toll Free – +1 800-961-0353

Sales – [email protected]


Boyd S. Abbott

Leave a Reply

Your email address will not be published.